神经保护
神经炎症
神经科学
医学
炎症
受体
冲程(发动机)
免疫系统
信号转导
机制(生物学)
中枢神经系统
白细胞介素33
细胞因子
白细胞介素
免疫学
生物
细胞生物学
内科学
机械工程
哲学
认识论
工程类
作者
Shuang Guo,Chengli Qian,Wenfeng Li,Zhikun Zeng,Junlong Cai,Yi Luo
摘要
Interleukin (IL)-33 was initially recognized as a constituent of the IL-1 cytokine family in 2005. It exerts pleiotropic effects by regulating immune responses via its binding to the receptor ST2 (IL-33R). The IL-33/ST2 pathway has been linked to several inflammatory disorders. In human and rodents, the broad expression of IL-33 in spinal cord tissues and brain indicates its central nervous system-specific functions. Growing evidence supports the protective effects of the IL-33/ST2 pathway in ischemic stroke, along with a better understanding of the underlying mechanisms. IL-33 plays a crucial role in the regulation of the release of inflammatory molecules from glial cells in response to neuropathological lesions. Moreover, IL-33/ST2-mediated neuroprotection following cerebral ischemia may be linked to T-cell function, specifically regulatory T cells. Soluble ST2 (sST2) acts as a decoy receptor in the IL-33/ST2 axis, blocking IL-33 signaling through the membrane ST2 receptor. sST2 has also been identified as a potential inflammatory biomarker of ischemic stroke. Targeting sST2 specifically to eliminate its inhibition of the protective IL-33/ST2 pathway in ischemic brain tissues is a promising approach for the treatment of ischemic stroke.
科研通智能强力驱动
Strongly Powered by AbleSci AI